LCID
Lucid Group, Inc.
LCID has a slight edge over PATK overall, supported by stronger valuation and stronger fundamentals.
PATK
Patrick Industries, Inc.
PATK has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PATK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
PATK's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PATK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $25.09 | -68% |
| Fair | 16x | $61.65 | -22% |
| Forward | 17x | $78.59 | — |
| Current | 20x | $78.59 | — |
| Expensive | 22x | $85.00 | +8.2% |
Historical ranges are pointers, not guarantees.
PATK's PE is in its expensive range at 20x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PATK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PATK, with profitability holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
PATK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.70 | +22% |
| Q3 2026 | $3.84 | +10% |
| Q2 2026 | $4.21 | +14% |
| Q1 2026 | $3.89 | -6.5% |
| Q4 2025 | $3.90 | -5.1% |
| Q3 2025 | $3.49 | -25% |
| Q2 2025 | $3.68 | -21% |
| Q1 2025 | $4.16 | -7.3% |
| Q4 2024 | $4.11 | -5.1% |
PATK has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PATK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PATK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $975.3M | 0% |
| Q2 2026 | $1B | -0.6% |
| Q1 2026 | $997.2M | -0.6% |
| Q4 2025 | $924.2M | +9.2% |
| Q3 2025 | $975.6M | +6.1% |
| Q2 2025 | $1B | +3% |
| Q1 2025 | $1B | +7.5% |
| Q4 2024 | $846.1M | +8.3% |
PATK's revenue fell from its 2022 peak and has held roughly level since: $975M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | -1.7 points |
| Q2 2026 | 7.4% | -0.9 points |
| Q1 2026 | 6.5% | 0 points |
| Q4 2025 | 6.2% | +1.5 points |
| Q3 2025 | 6.8% | -1.3 points |
| Q2 2025 | 8.3% | -0.1 points |
| Q1 2025 | 6.5% | +0.2 points |
| Q4 2024 | 4.7% | -2.7 points |
PATK has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PATK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58.4M | +$75.6M |
| Q2 2026 | $65.3M | -50% |
| Q1 2026 | -$32.9M | -265% |
| Q4 2025 | $112.7M | +46% |
| Q3 2025 | -$17.2M | -151% |
| Q2 2025 | $131.1M | +8.7% |
| Q1 2025 | $19.9M | +1.1% |
| Q4 2024 | $77.2M | -25% |
PATK has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
PATK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.9% | -1.3M shares |
| 1 year | -6.9% | -2.4M shares |
| 3 years | -0.5% | -171K shares |
| 5 years | -7% | -2.4M shares |
| Available history | -6.5% | -2.3M shares |
PATK has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $91.4M |
| Q1 2026 | $14.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $23.5M |
| Q1 2025 | $8.5M |
| Q4 2024 | $4.7M |
PATK spent $106M buying back its own shares over the past year, up 190% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PATK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 2.8x | Moderate |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.0x | Elevated |
PATK's net debt is about 3.2 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PATK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.4 | Neutral |
| Stochastic | 58.7 | Neutral |
PATK's weekly RSI is 46 (neutral) and its Stochastic is 59 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PATK PE vs Consumer Cyclical Sector
| Metric | PATK | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 18x | 14% above |
| PE % | 74 | 47 | 27 pts above |
PATK is trading at 20x earnings, a 14% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PATK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.4 | 10% above |
| 20 week MA | $78.0 | 0.7% above |
| 50 week MA | $97.1 | 19% below |
| 100 week MA | $95.8 | 18% below |
| 200 week MA | $80.6 | 2.5% below |
PATK has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PATK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.0 | $46.9 | +34% |
| 2021 | $46.9 | $52.6 | +12% |
| 2022 | $52.6 | $40.8 | -23% |
| 2023 | $40.8 | $66.9 | +64% |
| 2024 | $66.9 | $83.5 | +25% |
| 2025 | $83.5 | $112.1 | +34% |
| 2026 YTD | $112.1 | $78.6 | -30% |
PATK has the edge over LCID on returns for 2026, with the stronger performance.